Cigna Holding Company
Location
Connecticut
Founded
1792-02-28
Website
Risk Signals
5792 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Life Insurance, Accident and Health Insurance, Hospital and Medical Service Plans, Surety Insurance), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cigna Holding Company
Live alerts from global media, monitored by Business Radar
2025-04-13 (pymnts.com)
Canada Probes Express Scripts Over Alleged Anti-Competitive Conduct |
Canada's Competition Bureau has initiated a formal investigation into Express Scripts, the pharmacy services division of U.S.-based health...
Read more
2025-04-11 (wcbm.com)
Canada launches probe into Cigna's Express Scripts -
(Reuters) – Canada's Competition Bureau said on Friday it has launched an investigation into Cigna's pharmacy benefit management unit Express Scripts. The agency is looking into alleged anti-competitive conduct that can prevent or limit competition in the pharmacy retail market, the bureau said. (Reporting by Sneha S K; Editing by Leroy Leo) Brought to you by www.srnnews.com
Read more
2025-04-07 (beckershospitalreview.com)
FTC chair joins PBM case - Becker's Hospital Review | Healthcare News & Analysis
The U.S. Federal Trade Commission's lawsuit against major pharmacy benefit managers, including UnitedHealth Group's Optum, CVS Health's Caremark and Cigna's Express Scripts, over insulin pricing practices is set to move forward after being paused last week. FTC chair Andrew Ferguson said April 3 that he would no longer recuse himself from the case, clearing the […]
Read more
2025-03-21 (fiercehealthcare.com)
FTC commissioner firings spark legal uncertainty in PBM insulin case
Controversial firings at the Federal Trade Commission could lead to an unprecedented legal conundrum at the heart of an upcoming PBM insulin lawsuit.
Read more
2025-03-17 (wdbj7.com)
Anthem, Cigna ordered to reimburse hundreds of customers
Health insurance companies Anthem and Cigna have been ordered by the Virginia State Corporation Commission to reimburse hundreds of Virginians who were overcharged.
Read more
2025-02-19 (modernhealthcare.com)
CVS Caremark, Express Scripts, OptumRx lose bid to stop FTC case |
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case against their PBMs.
Read more
2025-01-24 (pymnts.com)
Prime Therapeutics Found in Violation of Antitrust Laws, Arbitrator Rules |
An arbitrator has ruled that Prime Therapeutics, a PBM owned by Blue Cross Blue Shield state plans, violated federal and state antitrust...
Read more
2024-11-15 (kaufmanhall.com)
Gist Weekly: November 15, 2024
DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program.
Read more
2024-11-12 (healthleadersmedia.com)
Cigna won't pursue deal with rival Humana, shares rise
Cigna Group said Monday it is not pursuing a combination with rival Humana, days after Donald Trump's reelection as U.S. president raised investor hopes that any merger would face far less antitrust scrutiny.
Read more
2024-11-06 (ajmc.com)
Cigna-Humana Resume Megamerger Talks: Impact on Stakeholders, Health Outcomes, and Cost
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of the presidential election.
Read more
2024-10-11 (techtarget.com)
PBMs call for FTC commissioners' recusal from antitrust case
Cigna, UnitedHealth and CVS Caremark urge FTC commissioners to recuse from the ongoing antitrust case, citing bias and lack of impartiality.
Read more
2024-10-04 (healthexec.com)
Texas sues PBMs and drug manufacturers for insulin price collusion
Two weeks ago, the FTC launched a similar antitrust suit. The pharmacy benefit managers and pharmaceutical companies are accused of artificially raising drug costs through rebates and kickbacks.
Read more